Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$145K Hold
3,388
– – 0.08% 135
2026
Q1
$163K Hold
3,388
– – 0.08% 130
2025
Q4
$164K Sell
3,388
-90
-3% -$4.46K 0.09% 129
2025
Q3
$164K Hold
3,478
– – 0.1% 127
2025
Q2
$168K Sell
3,478
-50
-1% -$2.56K 0.1% 134
2025
Q1
$196K Sell
3,528
-1,360
-28% -$73.6K 0.13% 123
2024
Q4
$236K Buy
4,888
+680
+16% +$34.6K 0.15% 114
2024
Q3
$243K Sell
4,208
-100
-2% -$5.4K 0.15% 112
2024
Q2
$209K Hold
4,308
– – 0.13% 127
2024
Q1
$209K Buy
4,308
+30
+0.7% +$1.47K 0.13% 125
2023
Q4
$213K Buy
+4,278
New +$209K 0.15% 118

Other funds holding SNY

Hara Capital's SNY Position: Q2 2026 in Review

Hara Capital held its Sanofi (SNY) position steady in Q2 2026 at 3,388 shares worth $145K. The position accounts for 0.08% of the portfolio, ranked #135.

Hara Capital first reported a position in SNY in Q4 2023 and has held it in 11 quarters since. The position peaked at $243K in Q3 2024. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Hara Capital held 3,388 shares of Sanofi worth $145K as of Q2 2026.
  • Hara Capital left its Sanofi share count unchanged in Q2 2026.
  • Sanofi made up 0.08% of Hara Capital's portfolio in Q2 2026, its #135 holding.
  • Hara Capital first reported a position in Sanofi in Q4 2023 and has held it in 11 quarters since.
  • Hara Capital's Sanofi position peaked at $243K in Q3 2024.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Hara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.